Functionalized Lipid Carriers for Nucleic-Acid and Drug Therapeutics
用于核酸和药物治疗的功能化脂质载体
基本信息
- 批准号:10020420
- 负责人:
- 金额:$ 29.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcidsAdhesionsAlbumin-Stabilized Nanoparticle PaclitaxelBiologicalBiological AssayBiophysicsCancer cell lineCapsidCationsCell SurvivalCellsChargeChemicalsChemistryChemotherapy-Oncologic ProcedureClinical TrialsCodeCommunitiesComplexConeCustomCyclic PeptidesCytosolDNADataDependenceDevelopmentDistalDrug Delivery SystemsElectron MicroscopyElectrostaticsEncapsulatedEndosomesEngineeringExcisionExonsFluorescence MicroscopyGene DeliveryGene SilencingGenesGoalsHomingHospitalsHumanHydrophobicityHypersensitivityIn VitroIntronsKnowledgeLaboratoriesLigandsLipid BilayersLipidsLiposomesMalignant NeoplasmsMediatingMembraneMethodsMicellesModernizationNon-Viral VectorNucleic AcidsOrganellesOrganic ChemistryPaclitaxelPenetrationPeptidesPharmaceutical PreparationsPhaseProbabilityPropertyProteinsRNAReactionResearchResearch ActivityRoentgen RaysSafetyScienceShapesSmall Interfering RNASolidSolubilityStructureSynchrotronsTailTechniquesTestingTherapeuticTransfectionTumor TissueUntranslated RNAVesicleViral VectorVirusX ray diffraction analysisbasebiophysical analysisbiophysical propertiesbiophysical techniquescancer cellchemical propertycryogenicscytotoxiccytotoxicitydesigndisorder controlefficacy testingethylene glycolgene therapyhuman modelimmunogenicimmunogenicityin vivoliposome vectormalignant stomach neoplasmmouse modelnanoparticlenanoscalenovelnucleic acid deliverynucleic acid-based therapeuticsphysical propertytooltumoruptakevector
项目摘要
Project Summary/Abstract
The current level of research activity involving gene therapy with either synthetic vectors (carriers) or engineered viruses
is unprecedented. Liposomes are the most widely studied nonviral carriers worldwide for nucleic acid (NA) and drug
delivery applications. Cationic liposomes (CLs) are relatively safe nonviral vectors used in ongoing clinical trials. CLs
may either be complexed via electrostatic interactions with therapeutic NAs (anionic DNA or short interfering RNA) for
gene delivery and silencing, or used as vectors of potent cytotoxic hydrophobic drugs, encapsulated within their lipid
bilayer, in cancer therapeutics. Among the biggest advantages of nonviral vectors (over viral vectors which are currently
more efficient in in vivo settings) are their safety, their low immunogenicity and their ability to transfer entire genes
(containing coding and noncoding sequences) and regulatory sequences into cells (currently not feasible with engineered
viruses because of capsid size limitations). The development of nonviral lipid-based vectors with efficacy competitive
with viral vectors in vivo will require a mechanistic understanding of how synthetic vectors may be functionalized to
overcome the major intracellular hurdle of endosomal escape. Successful endosomal escape is required for release of
therapeutic nucleic acid within the cell cytosol and therefore maximum efficacy. The first aim of this research application
is to employ modern biophysical and synthetic approaches to the rational design of functionalized CL–NA nanoparticles
(NPs) with synergistic, complementary dual-function PEG-lipid and fusogenic components for optimized endosomal
escape. Modern methods of organic and solid phase chemistry will be employed to synthesize dual-function PEG-lipids
with cell targeting and endosome escaping properties. The second aim of this research application is to optimize efficacy
of a new class of CL-based carriers of the hydrophobic drug paclitaxel (PTXL) for cancer therapeutics. This will be
achieved by developing a mechanistic understanding of the relation between physical and chemical properties of the
carrier (i.e. size of the functionalized CL carrier, membrane spontaneous curvature, and lipid tail structure) and functional
efficacy (i.e. PTXL membrane solubility, cell uptake of vector and PTXL delivery leading to cytotoxicity against human
cancer cells). The structures of CL-based vectors of NAs and hydrophobic drugs will be characterized using cryogenic
electron microscopy and synchrotron x-ray diffraction techniques. The interactions between CL vectors and cell
organelles will be directly visualized with spinning disk confocal fluorescence microscopy. Their structures will be
correlated to their biological activity in human cancer cells. The broad, long-term objective of our research is to develop a
fundamental science base through mechanistic studies that will lead to the design and synthesis of nonviral vectors of
nucleic acids and hydrophobic drugs for gene and cancer therapeutics.
项目概要/摘要
目前涉及使用合成载体(载体)或工程病毒进行基因治疗的研究活动水平
是前所未有的。脂质体是全球研究最广泛的核酸(NA)和药物非病毒载体
交付应用程序。阳离子脂质体(CL)是正在进行的临床试验中使用的相对安全的非病毒载体。化学发光
可以通过静电相互作用与治疗性 NA(阴离子 DNA 或短干扰 RNA)复合,
基因传递和沉默,或用作强效细胞毒性疏水性药物的载体,封装在其脂质内
双层,用于癌症治疗。非病毒载体的最大优点之一(相对于目前流行的病毒载体)
在体内环境中更有效)是它们的安全性、低免疫原性和转移整个基因的能力
(包含编码和非编码序列)和调节序列进入细胞(目前对于工程改造不可行)
病毒,因为衣壳大小限制)。具有功效竞争性的非病毒脂质载体的开发
在体内使用病毒载体需要对合成载体如何功能化有机械性的了解
克服内体逃逸的主要细胞内障碍。释放需要成功的内体逃逸
治疗性核酸位于细胞胞浆内,因此具有最大功效。本研究应用的第一个目标
是采用现代生物物理和合成方法来合理设计功能化的CL-NA纳米粒子
(NP) 具有协同、互补的双功能 PEG-脂质和融合成分,可优化内体
逃脱。现代有机和固相化学方法将用于合成双功能PEG-脂质
具有细胞靶向和内体逃逸特性。该研究应用的第二个目标是优化功效
用于癌症治疗的疏水性药物紫杉醇 (PTXL) 的一类新型基于 CL 的载体的研究。这将是
通过发展对物理和化学性质之间关系的机械理解来实现
载体(即功能化 CL 载体的大小、膜自发曲率和脂质尾结构)和功能
功效(即 PTXL 膜溶解度、载体的细胞摄取和 PTXL 递送导致对人类的细胞毒性)
癌细胞)。基于 CL 的 NA 和疏水性药物载体的结构将使用低温进行表征
电子显微镜和同步加速器X射线衍射技术。 CL载体与细胞之间的相互作用
细胞器将通过转盘共聚焦荧光显微镜直接可视化。他们的结构将是
与其在人类癌细胞中的生物活性相关。我们研究的广泛、长期目标是开发一种
通过机制研究建立基础科学基础,这将导致非病毒载体的设计和合成
用于基因和癌症治疗的核酸和疏水性药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CYRUS R SAFINYA其他文献
CYRUS R SAFINYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CYRUS R SAFINYA', 18)}}的其他基金
Functionalized Lipid Carriers for Nucleic-Acid and Drug Therapeutics
用于核酸和药物治疗的功能化脂质载体
- 批准号:
9789048 - 财政年份:2018
- 资助金额:
$ 29.56万 - 项目类别:
Functionalized Lipid Carriers for Nucleic-Acid and Drug Therapeutics
用于核酸和药物治疗的功能化脂质载体
- 批准号:
10242074 - 财政年份:2018
- 资助金额:
$ 29.56万 - 项目类别:
STRETCHING THE LIMITS OF MEMBRANE CHARGE DENSITY USING DENDRIMER LIPIDS
使用树枝状脂质扩展膜电荷密度的极限
- 批准号:
8362446 - 财政年份:2011
- 资助金额:
$ 29.56万 - 项目类别:
SYNCHROTRON X-RAY STUDIES OF BIOMOLECULAR MATERIALS
生物分子材料的同步辐射 X 射线研究
- 批准号:
8362233 - 财政年份:2011
- 资助金额:
$ 29.56万 - 项目类别:
STERICALLY STABILIZED CATIONIC LIPID - DNA COMPLEXES USED IN GENE DELIVERY
空间稳定的阳离子脂质 - 用于基因传递的 DNA 复合物
- 批准号:
8362475 - 财政年份:2011
- 资助金额:
$ 29.56万 - 项目类别:
STRETCHING THE LIMITS OF MEMBRANE CHARGE DENSITY USING DENDRIMER LIPIDS
使用树枝状脂质扩展膜电荷密度的极限
- 批准号:
8169665 - 财政年份:2010
- 资助金额:
$ 29.56万 - 项目类别:
SYNCHROTRON X-RAY STUDIES OF BIOMOLECULAR MATERIALS
生物分子材料的同步辐射 X 射线研究
- 批准号:
8169977 - 财政年份:2010
- 资助金额:
$ 29.56万 - 项目类别:
SYNCHROTRON X-RAY STUDIES OF BIOMOLECULAR MATERIALS
生物分子材料的同步辐射 X 射线研究
- 批准号:
8170193 - 财政年份:2010
- 资助金额:
$ 29.56万 - 项目类别:
STRETCHING THE LIMITS OF MEMBRANE CHARGE DENSITY USING DENDRIMER LIPIDS
使用树枝状脂质扩展膜电荷密度的极限
- 批准号:
7956428 - 财政年份:2009
- 资助金额:
$ 29.56万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 29.56万 - 项目类别:
Continuing Grant
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 29.56万 - 项目类别:
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 29.56万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 29.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 29.56万 - 项目类别:
Continuing Grant
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 29.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 29.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 29.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 29.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 29.56万 - 项目类别:
Operating Grants














{{item.name}}会员




